- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
November 9th, 2005
A novel medication called a nanoviricide, being developed by Westhaven, Connecticut-based NanoViricides, Inc, is likely to prove much more efficacious in treating patients infected by the deadly Avian flu than current favourites like oseltamivir (TamiFlu) of Roche and zanamivir (Relenza) of GlaxoSmithKline.
The key intellectual property on which the new drug is based is a flexible nanomaterial that contains an encapsulated active pharmaceutical ingredient and, using a ligand, targets it to a specific type of virus.
|Related News Press|
Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015
Draw out of the predicted interatomic force August 30th, 2015
Nanocatalysts improve processes for the petrochemical industry August 28th, 2015
Successful boron-doping of graphene nanoribbon August 27th, 2015
Developing Component Scale Composites Using Nanocarbons August 26th, 2015
Seeing quantum motion August 30th, 2015
Artificial leaf harnesses sunlight for efficient fuel production August 30th, 2015